|
Volumn 351, Issue 6271, 2016, Pages 403-407
|
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CRISPR ASSOCIATED PROTEIN;
CRISPR ASSOCIATED PROTEIN 9;
DYSTROPHIN;
GENOMIC DNA;
MESSENGER RNA;
NEURONAL NITRIC OXIDE SYNTHASE;
PARVOVIRUS VECTOR;
UNCLASSIFIED DRUG;
BIOCHEMICAL COMPOSITION;
GENE EXPRESSION;
GENOME;
MUSCLE;
MUTATION;
NUMERICAL MODEL;
PROTEIN;
RODENT;
SKELETON;
VIRUS;
ADULT;
ANIMAL CELL;
ANIMAL MODEL;
ARTICLE;
CELL LYSATE;
CONTROLLED STUDY;
CRISPR CAS SYSTEM;
DUCHENNE MUSCULAR DYSTROPHY;
ENZYME ACTIVITY;
EXON SKIPPING;
GENE EXPRESSION;
GENE MUTATION;
GENOME EDITING;
HEART MUSCLE;
IMMUNOFLUORESCENCE;
IN VIVO STUDY;
MOUSE;
MUSCLE CONTRACTILITY;
MUSCLE FUNCTION;
MUSCLE STRENGTH;
NONHUMAN;
NONSENSE MUTATION;
PRIORITY JOURNAL;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
TIBIALIS ANTERIOR MUSCLE;
VIRAL GENE DELIVERY SYSTEM;
WESTERN BLOTTING;
X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;
ADENO-ASSOCIATED VIRUS;
MUS;
|
EID: 84963940775
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aad5143 Document Type: Article |
Times cited : (918)
|
References (43)
|